Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

NCT00649779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: albuterol sulfate extended-release 8 mg tablets
DRUG: VoSpire™ ER 8 mg tablets

Sponsor

Mylan Pharmaceuticals Inc